GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Applied Therapeutics Inc (FRA:2UV) » Definitions » 5-Year Yield-on-Cost %

Applied Therapeutics (FRA:2UV) 5-Year Yield-on-Cost % : 0.00 (As of Apr. 28, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Applied Therapeutics 5-Year Yield-on-Cost %?

Applied Therapeutics's yield on cost for the quarter that ended in Dec. 2024 was 0.00.


The historical rank and industry rank for Applied Therapeutics's 5-Year Yield-on-Cost % or its related term are showing as below:



FRA:2UV's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.715
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Applied Therapeutics's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Applied Therapeutics's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Applied Therapeutics's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Applied Therapeutics's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Applied Therapeutics's 5-Year Yield-on-Cost % falls into.


;
;

Applied Therapeutics 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Applied Therapeutics is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Applied Therapeutics  (FRA:2UV) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Applied Therapeutics 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Applied Therapeutics's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Applied Therapeutics Business Description

Traded in Other Exchanges
Address
545 Fifth Avenue, Suite 1400, New York, NY, USA, 10017
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Applied Therapeutics Headlines

No Headlines